Suppliers / Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory

Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory

China 1 employees Updated 9 July 2026

The public registers hold a second record for Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. The fuller profile, with 9 active US DMFs and 8 valid CEPs, is at Zhejiang Medicine. Figures on this page cover only this record.

Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory is an API manufacturer based in China. It holds 8 active US drug master files across a filed portfolio of 8 molecules. Its GMP standing is certified by MFDS (Korea), MHRA (UK) and US FDA. Its most recent recorded inspection, by US FDA, closed on 7 March 2025 as VAI.

8
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
7
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 7 March 2025 VAI US FDA
  • 30 November 2018 VAI US FDA
  • 30 June 2017 VAI US FDA
  • 18 June 2015 OAI US FDA
  • 17 January 2013 NAI US FDA
  • 16 April 2010 VAI US FDA
  • 11 March 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Xinchang, China Not on file
Shaoxing, China Not on file
XINCHANG, China Not on file
China, China 3003631275

What they file, and where

Molecule Regulators Docs
Bosentan US FDA 1
Daptomycin US FDA 1
Icosapent Ethyl US FDA 1
Levofloxacin US FDA 1
Miglitol US FDA 1
Minocycline US FDA 1
Rifaximin US FDA 1
Vancomycin US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
NMPA (CN) 7 None
MFDS (Korea) None 2
MHRA (UK) None 1
US FDA None 1

Questions about Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory

Does Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory hold a US DMF or a CEP?
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory holds 8 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory FDA-registered?
One site operated by Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory's last inspection go?
The most recent inspection on record closed on 7 March 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 7 inspections are on file, of which 1 closed as OAI.
Where does Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory manufacture?
4 registered sites are on record, in China (Xinchang, Shaoxing and Xinchang among others). Every site is listed on this page with the register it came from.
What does Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory make?
8 molecules are on record against Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory, including Bosentan, Daptomycin, Icosapent Ethyl and Levofloxacin. Each links through to that molecule's full manufacturer list.
Which regulators recognise Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory's GMP?
Current GMP certificates are on record from MFDS (Korea), MHRA (UK) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 7 March 2025.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates